Preterm Rupture of Membranes clinical trials at UCSF
1 research study open to eligible people
open to eligible females ages 18-55
This study evaluates the use of metagenomic next generation sequencing in identifying microbial DNA in plasma samples of patients with preterm premature rupture of membranes.
San Francisco, California